S. Madueño

A project presented to The California Commission on Peace Officer Standards and Training

Captain Eddie, S. Madueño, S. Madueno, 2009 .

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

Jeffrey A. Cohen, Islam M. Zaydan, Gregory F. Wu, 2022, The Lancet Neurology.

Gender Gap in the Leadership of Health Institutions: The Influence of Hospital-Level Factors

J. Montaner, S. Madueño, S. Pérez-Sánchez, 2021, Health equity.

Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry

S. Saidha, M. Onofrj, S. Galetta, 2021, Journal of the Neurological Sciences.

Real-World Experience with Cladribine in the MSBase Registry

F. Grand'Maison, H. Butzkueven, A. van der Walt, 2022, Multiple Sclerosis and Related Disorders.

Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis

E. Leray, J. Lechner-Scott, S. Vukusic, 2021, Neurology.

Usefulness of optic nerve ultrasound to predict clinical progression in multiple sclerosis

G. Izquierdo, Á. Vilches-Arenas, M. R. Hidalgo, 2019 .